PROFESSOR HONOURED FOR HER WORK ON PANDEMIC CONTROL
A Women in Science event held earlier this year demonstrated that women are certainly coming into their own in the fields of science, technology, engineering and maths.
In this, the final feature in a three-part...
Making clinical trials right for older people
In this issue, we speak to Miles Witham, Professor of Trials for Older People at Newcastle University and consultant geriatrician, about why he’s bringing about a sea change in how clinical trials involving older...
Breaking boundaries in bio manufacturing
Eric Fua, Conference Producer, IMAPAC UK, investigates the challenges and opportunities facing the biomanufacturing industry.
Last year, the global biomanufacturing market surged to an astounding US$19.02 billion, signifying the sector’s potential to revolutionise global health.1
Biopharmaceutical...
T cells: their increasing significance in infectious disease diagnosis and research
Peter Wrighton-Smith, CEO of Oxford Immunotec, talks to Bioscience Today about growing understanding of the importance of T cells in protecting us from disease, as well as their critical role in measuring immune responses...
Llamas: leading the pack in new cancer therapy
Llama antibodies - known as VHHs or nanobodies - could be a gamechanger for precision medicine. Marion Cubitt, Director of Discovery at Isogenica, explains how an accidental discovery opened a fresh pathway for immunotherapy.
Tell...
Collaboration, Clustering and Converting
Partnerships between small biotechs and Big Pharma could unlock faster drug development for rare diseases, says Dan Williams, PhD, CEO of SynaptixBio.
In an increasingly interconnected and competitive world, collaboration has become an essential tool...